Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natàlia Lloveras

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Medicina Clinica|September 23, 2003
[Composite lymphoma]Natàlia Lloveras, Esther Pleusa, Montserrat Batlle, et al.
Haematologica|June 1, 2005
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapyJosé-Tomás Navarro, Natàlia Lloveras, Josep-Maria Ribera, et al.
Human Immunology|June 13, 2013
Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcriptionArianne Pérez-García, Gemma Osca, Anna Bosch-Vizcaya, et al.
Frontiers in Immunology|May 1, 2023
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, et al.
Frontiers in Immunology|March 8, 2024
CD200 genotype is associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Gemma Osca-Gelis, Rocío Rodriguez-Romanos, et al.
Leukemia|March 11, 2020
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapyJohana Díaz-Santa, Rocío Rodríguez-Romanos, Gemma Osca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2011
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donorsAnna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet, et al.
Frontiers in Immunology|February 6, 2023
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donorsDavid Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, et al.
European Journal of Haematology|September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogeneticsJohana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medicina Clinica|September 23, 2003
[Composite lymphoma]Natàlia Lloveras, Esther Pleusa, Montserrat Batlle, et al.
Haematologica|June 1, 2005
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapyJosé-Tomás Navarro, Natàlia Lloveras, Josep-Maria Ribera, et al.
Human Immunology|June 13, 2013
Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcriptionArianne Pérez-García, Gemma Osca, Anna Bosch-Vizcaya, et al.
Frontiers in Immunology|May 1, 2023
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, et al.
Frontiers in Immunology|March 8, 2024
CD200 genotype is associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Gemma Osca-Gelis, Rocío Rodriguez-Romanos, et al.
Leukemia|March 11, 2020
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapyJohana Díaz-Santa, Rocío Rodríguez-Romanos, Gemma Osca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2011
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donorsAnna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet, et al.
Frontiers in Immunology|February 6, 2023
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donorsDavid Cruz, Rocío Rodríguez-Romanos, Marta González-Bartulos, et al.
European Journal of Haematology|September 5, 2022
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogeneticsJohana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, et al.
Pageof 1